A home health nurse is making a home visit to a client with multiple sclerosis. The nurse reviews the home medications taken by the client. Which question should the nurse ask to determine the effectiveness of the client's medication, baclofen (Lioresal)?

A) Prednisone:
Prednisone is a corticosteroid commonly used to reduce inflammation in conditions such as asthma. It is appropriate in this case for managing the asthma exacerbation, as steroids help to decrease airway inflammation and improve breathing. There is no immediate concern about prednisone in this client with both asthma and a history of heart failure.

B) Metoprolol:
Metoprolol is a beta-blocker, typically used for managing heart failure, hypertension, and arrhythmias. However, beta-blockers are generally avoided in asthma patients because they can exacerbate bronchospasm. In patients with asthma, beta-blockers can block beta-2 receptors in the lungs, leading to constriction of the airways and worsening respiratory symptoms.

C) Labetolol:
Labetolol is a beta-blocker with both alpha- and beta-blocking effects, which can help lower blood pressure and manage heart failure. While labetalol can also block beta-2 receptors, it has a relatively lower risk of causing bronchospasm compared to non-selective beta-blockers like metoprolol. However, it still poses some risk to patients with asthma. Given the patient's history of asthma, labetolol may still require caution, but it is generally considered safer than other beta-blockers.

D) Albuterol:
Albuterol is a bronchodilator used to relieve acute asthma symptoms and is commonly prescribed for asthma exacerbations. It works by stimulating beta-2 receptors in the lungs, leading to the relaxation of bronchial smooth muscles and improved airflow. In this case, albuterol is an appropriate medication for managing asthma exacerbation and should be used to relieve symptoms of shortness of breath and wheezing.

A) A normal finding:
A normal finding during an edrophonium (Tensilon) test is an improvement in muscle strength for clients with myasthenia gravis (MG). If the client becomes weaker after the dose, it indicates that the test results are not typical and suggest a different issue, not a normal response. This is not a normal finding.

B) A myasthenia gravis crisis due to drug undermedication:
In a myasthenic crisis, the client experiences severe weakness and respiratory difficulty, typically due to insufficient medication (e.g., pyridostigmine). While a myasthenic crisis could cause weakness and respiratory distress, the edrophonium test would typically show improvement in muscle strength if the crisis is due to undermedication. Since the client became weaker after receiving edrophonium, this is not indicative of a myasthenic crisis.

C) An allergic reaction:
An allergic reaction to the edrophonium test would typically result in symptoms such as rash, swelling, or difficulty breathing due to hypersensitivity, but it does not typically cause weakness as the primary response. The worsening of symptoms after the test is more likely related to drug overmedication rather than an allergic reaction.

D) A cholinergic crisis due to drug overmedication:
A cholinergic crisis occurs when there is an overdose of acetylcholinesterase inhibitors (e.g., pyridostigmine or neostigmine), which can lead to excessive acetylcholine at the neuromuscular junction, resulting in muscle weakness and respiratory failure. The edrophonium test helps differentiate between a myasthenic crisis and a cholinergic crisis. If the client becomes weaker after the administration of edrophonium, it suggests a cholinergic crisis due to drug overmedication.